TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 25085109

Group type: EXPERIMENTAL
Intervention: Voxel-based statistical procedure (SPM)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Standard visual analysis (SVA)
Number of subjects: 71
Study: 23891440

Group type: EXPERIMENTAL
Intervention: High-protein diet enriched with β-hydroxy-β-methylbutirate, calcium, and vitamin D administered during 30 days of hospitalization.
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control diet administered during 30 days of hospitalization.
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: High-protein diet enriched with β-hydroxy-β-methylbutirate, calcium, and vitamin D.
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control diet.
Number of subjects: 100
Study: 21733833

Group type: EXPERIMENTAL
Intervention: Motivational Enhancement Therapy (MET)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Social Behaviour and Network Therapy (SBNT)
Number of subjects: 0
Study: 19687343

Group type: EXPERIMENTAL
Intervention: Atorvastatin (ATOR) 80 mg/d for 12 weeks
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo for 12 weeks
Number of subjects: 26
Study: 16544453

Group type: EXPERIMENTAL
Intervention: Nurse-led fall prevention program including training nurses in the use of the Morse Fall Scale and implementing 15 selected preventive interventions.
Number of subjects: 409

Group type: COMPARATOR
Intervention: Usual-care group (control).
Number of subjects: 409
Study: 12637119

Group type: EXPERIMENTAL
Intervention: Choline alfoscerate (CA) 400 mg capsules, 3 times daily for 180 days
Number of subjects: 261

Group type: COMPARATOR
Intervention: Placebo capsules, 3 times daily for 180 days
Number of subjects: 261

Group type: EXPERIMENTAL
Intervention: Choline alfoscerate (CA)
Number of subjects: 261

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 261
Study: 10695935

Group type: EXPERIMENTAL
Intervention: Doxycycline hyclate (DH)
Number of subjects: 141

Group type: COMPARATOR
Intervention: Scaling and root planing (SRP)
Number of subjects: 141
Study: 9198257

Group type: EXPERIMENTAL
Intervention: Intensive 3-week multidisciplinary program
Number of subjects: 123

Group type: COMPARATOR
Intervention: Active physical training and back school (Program 2)
Number of subjects: 123

Group type: COMPARATOR
Intervention: Psychological pain management and active physical training (Program 3)
Number of subjects: 123
Study: 1287138

Group type: EXPERIMENTAL
Intervention: Ceftibuten 400 mg once daily
Number of subjects: 123

Group type: COMPARATOR
Intervention: Co-amoxiclav 500 mg three times daily
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Ceftibuten
Number of subjects: 123

Group type: COMPARATOR
Intervention: Co-amoxiclav
Number of subjects: 123
Study: 3933134

Group type: EXPERIMENTAL
Intervention: 10% mannitol mechanical bowel preparation combined with oral neomycin and short-term, perioperative intravenous Flagyl (group I)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Oral neomycin and intravenous placebo (group II)
Number of subjects: 68
Study: 31064779

Group type: EXPERIMENTAL
Intervention: glasdegib + low-dose cytarabine (LDAC)
Number of subjects: 115

Group type: COMPARATOR
Intervention: low-dose cytarabine (LDAC) alone
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: glasdegib + LDAC
Number of subjects: 115
Study: 29050507

Group type: EXPERIMENTAL
Intervention: Progressive resistance strength training (twice a week for 12 weeks, load of 50% and 70% of one repetition maximum)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional drug treatment (Control Group)
Number of subjects: 60
Study: 26580234

Group type: EXPERIMENTAL
Intervention: Canagliflozin 100 mg
Number of subjects: 716

Group type: EXPERIMENTAL
Intervention: Canagliflozin 300 mg
Number of subjects: 716

Group type: EXPERIMENTAL
Intervention: Canagliflozin
Number of subjects: 716

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 716
Study: 24354834

Group type: EXPERIMENTAL
Intervention: Lactation Consultant (LC) + Electronically Prompted guidance (EP)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lactation Consultant (LC)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual Care
Number of subjects: 0
Study: 22277301

Group type: EXPERIMENTAL
Intervention: Lisdexamfetamine dimesylate (LDX)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61
Study: 19857509

Group type: EXPERIMENTAL
Intervention: Diacerein
Number of subjects: 1533

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1533
Study: 16980507

Group type: EXPERIMENTAL
Intervention: LNG + Meloxicam (Melox) 15 mg
Number of subjects: 41

Group type: COMPARATOR
Intervention: LNG + Placebo
Number of subjects: 41
Study: 16253100

Group type: COMPARATOR
Intervention: CAF
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: PRP + CAF
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 24
Study: 12037693

Group type: EXPERIMENTAL
Intervention: Losartan
Number of subjects: 55

Group type: COMPARATOR
Intervention: DASH diet
Number of subjects: 55

Group type: COMPARATOR
Intervention: Control diet
Number of subjects: 55
Study: 10208561

Group type: EXPERIMENTAL
Intervention: Go trials
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: No-go trials
Number of subjects: 0
Study: 7774474

Group type: EXPERIMENTAL
Intervention: Intense follow-up after curative surgery (clinical examination, rigid proctosigmoidoscopy, colonoscopy, CT of pelvis, pulmonary x-ray, liver function tests, carcinoembryonic antigen, fecal hemoglobin); follow-up duration ranged from 5.5 to 8.8 years.
Number of subjects: 107

Group type: COMPARATOR
Intervention: Control group with no follow-up; n = 54.
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Intense follow-up group; n = 53.
Number of subjects: 107

Group type: COMPARATOR
Intervention: Control group; n = 54.
Number of subjects: 107
Study: 2101381

Group type: EXPERIMENTAL
Intervention: Extra-protein rich diet (30% of ideal total calorie requirement)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Hospital diet (control group)
Number of subjects: 96
Study: 7007840

Group type: EXPERIMENTAL
Intervention: Continuous therapy with cimetidine (400 mg twice a day)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Intermittent therapy with cimetidine (six-week courses for each relapse)
Number of subjects: 48
Study: 31591903

Group type: EXPERIMENTAL
Intervention: Aerobic exercise program (3 times per week at 65%-75% of heart rate max for 45 minutes per session)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Aerobic exercise program
Number of subjects: 26
Study: 30429410

Group type: EXPERIMENTAL
Intervention: Diet
Number of subjects: 384

Group type: EXPERIMENTAL
Intervention: Diet + Activity
Number of subjects: 384

Group type: COMPARATOR
Intervention: Usual Care (Control)
Number of subjects: 384
Study: 27893326

Group type: EXPERIMENTAL
Intervention: Cisplatin and gemcitabine (platinum therapy)
Number of subjects: 648

Group type: COMPARATOR
Intervention: Paclitaxel and gemcitabine (nonplatinum therapy)
Number of subjects: 648

Group type: EXPERIMENTAL
Intervention: Cisplatin and pemetrexed (platinum therapy)
Number of subjects: 648

Group type: COMPARATOR
Intervention: Paclitaxel and pemetrexed (nonplatinum therapy)
Number of subjects: 648
Study: 25778467

Group type: EXPERIMENTAL
Intervention: GIK infusion for 12 hours
Number of subjects: 318
Study: 23337018

Group type: EXPERIMENTAL
Intervention: Moderate-resistance training (3 series of 8 to 15RM; nine exercises with 1-3 min rest between sets, three times a week for 8 weeks)
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Moderate-resistance training
Number of subjects: 2
Study: 21834960

Group type: EXPERIMENTAL
Intervention: Sorafenib
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 19619442

Group type: EXPERIMENTAL
Intervention: Hepatectomy with adjuvant transcatheter arterial chemoembolization (TACE)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Hepatectomy alone
Number of subjects: 108
Study: 18664063

Group type: EXPERIMENTAL
Intervention: Self-collected specimens
Number of subjects: 878

Group type: COMPARATOR
Intervention: Provider-collected samples
Number of subjects: 878

Group type: EXPERIMENTAL
Intervention: Overall HPV assessment
Number of subjects: 878

Group type: COMPARATOR
Intervention: Provider-collected specimens
Number of subjects: 878

Group type: EXPERIMENTAL
Intervention: Both specimens
Number of subjects: 878
Study: 16249701

Group type: EXPERIMENTAL
Intervention: Lopinavir/ritonavir monotherapy
Number of subjects: 42

Group type: COMPARATOR
Intervention: Lopinavir/ritonavir + 2 nucleosides (triple therapy)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Lopinavir/ritonavir monotherapy failures
Number of subjects: 42
Study: 12072676

Group type: EXPERIMENTAL
Intervention: Inhalation of air from a home humidifier generating O(2)(‐)(H(2)O)(n) for 4 hrs followed by positive ions from a jet nebulizer for 4 hrs
Number of subjects: 20

Group type: COMPARATOR
Intervention: Inhalation of positive ions for 4 hrs followed by inhalation of air from a home humidifier generating O(2)(‐)(H(2)O)(n) for 4 hrs
Number of subjects: 20
Study: 10443658

Group type: EXPERIMENTAL
Intervention: Insulin analog (Lispro)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Regular insulin (Velosuline)
Number of subjects: 10
Study: 7541026

Group type: EXPERIMENTAL
Intervention: SAWA bands of 153, 144, 38 and 32 kDa
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: SAWA bands of 144, 38, 32 and 18 kDa
Number of subjects: 0
Study: 2085987

Group type: EXPERIMENTAL
Intervention: Fosfomycin trometamol (FT, 3 g)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Trimethoprim (TMP, 200 mg)
Number of subjects: 51
Study: 6107592

Group type: EXPERIMENTAL
Intervention: Immunosuppressive treatment (antilymphocyte globulin, prednisolone, and azathioprine)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 30208421

Group type: EXPERIMENTAL
Intervention: Light therapy (delivered via a light-emitting mask, peak 505 nm, 23 scotopic Td), worn each night for 12 months
Number of subjects: 60

Group type: COMPARATOR
Intervention: Untreated control group
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Light therapy
Number of subjects: 60
Study: 27670977

Group type: EXPERIMENTAL
Intervention: HF‐rTMS
Number of subjects: 8

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 8
Study: 24178368

Group type: EXPERIMENTAL
Intervention: Vemurafenib 240 mg bid
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Vemurafenib 480 mg bid
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Vemurafenib 720 mg bid
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Vemurafenib 960 mg bid
Number of subjects: 52
Study: 22546036

Group type: EXPERIMENTAL
Intervention: Educational intervention lecture on injury prevention
Number of subjects: 1049

Group type: COMPARATOR
Intervention: Control group with no intervention
Number of subjects: 1049
Study: 20032275

Group type: EXPERIMENTAL
Intervention: Usual-care-plus-Internet support
Number of subjects: 72

Group type: COMPARATOR
Intervention: Usual-care
Number of subjects: 72
Study: 18633177

Group type: EXPERIMENTAL
Intervention: Telmisartan 40 mg once daily
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: Telmisartan 80 mg once daily
Number of subjects: 163

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 163
Study: 15868131

Group type: EXPERIMENTAL
Intervention: Subjective roughness scaling by 19 speech and voice therapy students
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Computer-aided measurement of vocal fold cycle irregularity (irregularity index)
Number of subjects: 78
Study: 12709818

Group type: EXPERIMENTAL
Intervention: Cipamfylline ointment
Number of subjects: 21

Group type: COMPARATOR
Intervention: Betamethasone-17-valerate
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo ointment
Number of subjects: 21
Study: 10595626

Group type: EXPERIMENTAL
Intervention: Enoxaparin
Number of subjects: 266

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 266
Study: 7480986

Group type: EXPERIMENTAL
Intervention: b.d. regimen (twice daily)
Number of subjects: 58

Group type: COMPARATOR
Intervention: q.d. regimen (four times a day)
Number of subjects: 58
Study: 2025036

Group type: EXPERIMENTAL
Intervention: Routine iron supplementation
Number of subjects: 2912

Group type: COMPARATOR
Intervention: Non-routine iron supplementation
Number of subjects: 2912

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 2912

Group type: EXPERIMENTAL
Intervention: High ratio for packed cell volume
Number of subjects: 2912
Study: 7402802

Group type: EXPERIMENTAL
Intervention: Rooming-in
Number of subjects: 301

Group type: COMPARATOR
Intervention: Control (routine postpartum contact)
Number of subjects: 301
Study: 31401726

Group type: EXPERIMENTAL
Intervention: Recurrent inguinal hernia repair
Number of subjects: 134391

Group type: COMPARATOR
Intervention: Primary inguinal hernia repair
Number of subjects: 134391
Study: 30919492

Group type: EXPERIMENTAL
Intervention: Rebamipide (300 mg/day)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 83
Study: 27836677

Group type: EXPERIMENTAL
Intervention: NEMEX therapy (neuro-muscular exercise) twice a week for 8 weeks
Number of subjects: 93

Group type: COMPARATOR
Intervention: PHARMA (instructions in optimized analgesics and anti-inflammatory drug use)
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: NEMEX therapy
Number of subjects: 93

Group type: COMPARATOR
Intervention: PHARMA
Number of subjects: 93

Group type: COMPARATOR
Intervention: NEMEX therapy and PHARMA
Number of subjects: 93
Study: 25831993

Group type: EXPERIMENTAL
Intervention: Isometric training at long muscle length (LL)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Isometric training at short muscle length (SL)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Both groups (LL and SL)
Number of subjects: 16
Study: 23415779

Group type: EXPERIMENTAL
Intervention: Topical cyclosporine A 0.05% emulsion twice daily for 3 months postoperatively
Number of subjects: 124

Group type: COMPARATOR
Intervention: Standard postoperative treatment regimen without topical cyclosporine A
Number of subjects: 124
Study: 21097795

Group type: EXPERIMENTAL
Intervention: Budesonide via Turbuhaler (TBH), twice daily
Number of subjects: 115
Study: 19154960

Group type: EXPERIMENTAL
Intervention: Antioxidant supplementation (vitamin E, 800 IU; vitamin C, 500 mg; beta-carotene, 10 mg)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Antioxidant supplementation
Number of subjects: 48
Study: 16776335

Group type: EXPERIMENTAL
Intervention: Gamma knife surgery to the retrogasserian cisternal portion of the fifth cranial nerve, median dose 85 Gy (range 70‐90 Gy)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Gamma knife surgery
Number of subjects: 100
Study: 15788983

Group type: EXPERIMENTAL
Intervention: Oligomineral water (1.5 liters daily for 4 weeks)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Tap water (1.5 liters daily for 4 weeks)
Number of subjects: 24
Study: 11316215

Group type: EXPERIMENTAL
Intervention: Lansoprazole 30 mg p.o. b.i.d. for 3 months
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 9135355

Group type: EXPERIMENTAL
Intervention: i.m. lignocaine
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: i.m. bupivacaine
Number of subjects: 90

Group type: COMPARATOR
Intervention: i.v. propofol
Number of subjects: 90
Study: 7895895

Group type: EXPERIMENTAL
Intervention: 100 mg low-molecular-weight dermatan sulphate
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 200 mg low-molecular-weight dermatan sulphate
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 100 mg and 200 mg low-molecular-weight dermatan sulphate
Number of subjects: 16
Study: 3313232

Group type: EXPERIMENTAL
Intervention: Acetaminophen
Number of subjects: 383

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 383
Study: 31462489

Group type: EXPERIMENTAL
Intervention: six-session VR cognitive treatment added to treatment as usual
Number of subjects: 432

Group type: COMPARATOR
Intervention: treatment as usual alone
Number of subjects: 432
Study: 28008080

Group type: EXPERIMENTAL
Intervention: 15 min of 10Hz rTMS stimulation (1500 pulses) at 110% of the individual motor threshold
Number of subjects: 23

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 23
Study: 25974049

Group type: EXPERIMENTAL
Intervention: High intensity functional exercise program (intensive strengthening and balance exercises in small groups twice a week for 12 weeks)
Number of subjects: 170

Group type: EXPERIMENTAL
Intervention: High intensity functional exercise program
Number of subjects: 170

Group type: COMPARATOR
Intervention: Leisure activities (control group)
Number of subjects: 170
Study: 23765237

Group type: EXPERIMENTAL
Intervention: Non-invasive ventilation (NIV)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Invasive mechanical ventilation (IMV)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Renal replacement therapy after invasive mechanical ventilation (RRT after IMV)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Knowledge of patient preferences
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Additional bed availability
Number of subjects: 100
Study: 21557648

Group type: EXPERIMENTAL
Intervention: Part-task condition
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Whole-task condition
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Individual differences in learning gains
Number of subjects: 0
Study: 17957221

Group type: EXPERIMENTAL
Intervention: Naltrexone (50 mg)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 17139955

Group type: EXPERIMENTAL
Intervention: Laparoscopic surgery for colon cancer
Number of subjects: 0

Group type: COMPARATOR
Intervention: Open surgical resection of the primary tumor
Number of subjects: 0
Study: 14731181

Group type: EXPERIMENTAL
Intervention: Vertical Guided Bone Regeneration (GBR) with autogenous bone and e-PTFE membranes; 25 implants placed.
Number of subjects: 21

Group type: COMPARATOR
Intervention: Distraction Osteogenesis (DO); 34 implants placed.
Number of subjects: 21
Study: 11269565

Group type: EXPERIMENTAL
Intervention: Lansoprazole
Number of subjects: 2
Study: 9425679

Group type: EXPERIMENTAL
Intervention: Splay texture
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Depression texture
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 0
Study: 8431592

Group type: EXPERIMENTAL
Intervention: Orthoplast cock-up splint
Number of subjects: 12

Group type: COMPARATOR
Intervention: Ready-made Camp Droitwich splint
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Both splints
Number of subjects: 12
Study: 3318450

Group type: EXPERIMENTAL
Intervention: Fenofibrate
Number of subjects: 6000000

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6000000
Study: 28671504

Group type: EXPERIMENTAL
Intervention: Amsterdam Cognition Scan (ACS)
Number of subjects: 201

Group type: COMPARATOR
Intervention: Traditional neuropsychological test battery
Number of subjects: 201

Group type: COMPARATOR
Intervention: Visuospatial memory test (part of traditional battery)
Number of subjects: 201
Study: 27994394

Group type: EXPERIMENTAL
Intervention: Olive tipped (OT) cannula
Number of subjects: 120

Group type: COMPARATOR
Intervention: Conventional Steven's cannula (ST)
Number of subjects: 120
Study: 24077863

Group type: EXPERIMENTAL
Intervention: Matched intervention targeting specific psychological profile
Number of subjects: 105

Group type: COMPARATOR
Intervention: Unmatched intervention
Number of subjects: 105
Study: 22624990

Group type: EXPERIMENTAL
Intervention: Zotarolimus-eluting stent
Number of subjects: 1052

Group type: COMPARATOR
Intervention: Sirolimus-eluting stent
Number of subjects: 1052
Study: 20838059

Group type: EXPERIMENTAL
Intervention: Preoperative chemoradiotherapy
Number of subjects: 38
Study: 18655559

Group type: EXPERIMENTAL
Intervention: Cuichan Zhusheng Decoction (CZD), 300 mL daily, taken orally for 3 days
Number of subjects: 90

Group type: COMPARATOR
Intervention: Pitocin, 1 U into 500 mL 5% glucose for intravenous dripping for 3 days
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo of CZD, administrated in the same way as treated group
Number of subjects: 90
Study: 15722401

Group type: EXPERIMENTAL
Intervention: Temazepam 10 mg
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Temazepam 20 mg
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15

Group type: COMPARATOR
Intervention: Temazepam (10 mg)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Follow-up
Number of subjects: 15
Study: 12866763

Group type: EXPERIMENTAL
Intervention: Radiofrequency ablation
Number of subjects: 30

Group type: COMPARATOR
Intervention: Amiodarone
Number of subjects: 30
Study: 11678951

Group type: EXPERIMENTAL
Intervention: Bilateral ventilation tubes with adjuvant adenoidectomy
Number of subjects: 506

Group type: EXPERIMENTAL
Intervention: Bilateral ventilation tubes without adjuvant adenoidectomy
Number of subjects: 506

Group type: COMPARATOR
Intervention: Non-surgical management
Number of subjects: 506

Group type: COMPARATOR
Intervention: Not recruited due to overriding concern
Number of subjects: 506

Group type: COMPARATOR
Intervention: Not randomized due to overriding concern
Number of subjects: 506

Group type: COMPARATOR
Intervention: Not randomized due to parental refusal
Number of subjects: 506
Study: 9751327

Group type: EXPERIMENTAL
Intervention: Extracorporeal shock wave lithotripsy (ESWL)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Observation (control)
Number of subjects: 0
Study: 7932990

Group type: EXPERIMENTAL
Intervention: Nomograms based on BPD, AC, and FL
Number of subjects: 243

Group type: EXPERIMENTAL
Intervention: Nomograms based on gestational age and transverse cerebellar diameter
Number of subjects: 243

Group type: EXPERIMENTAL
Intervention: Nomograms based on transverse cerebellar diameter
Number of subjects: 243

Group type: COMPARATOR
Intervention: Normal fetuses
Number of subjects: 243
Study: 3063479

Group type: EXPERIMENTAL
Intervention: KCl 20 mEq/65 ml iv with lidocaine 50 mg
Number of subjects: 18

Group type: COMPARATOR
Intervention: KCl 20 mEq/65 ml iv without lidocaine
Number of subjects: 18
Study: 29672578

Group type: EXPERIMENTAL
Intervention: MHC (manual, handover meeting, and three site visits)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: MH (manual plus handover meeting)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: M (written manual only)
Number of subjects: 0
Study: 26585585

Group type: EXPERIMENTAL
Intervention: ADSCs with fibrin glue and microfracture (MFX)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Microfracture (MFX) alone
Number of subjects: 80